Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2020 Filed Apr 29, 2020 11:09 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,862 | $5.97 | $17,071.83 |
DisclosureSEC source: 0001393726-20-000116 · wf-form4_158817297211203.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,327,763 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.89 to $6.04, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 28, 2020 Filed Apr 29, 2020 11:07 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.76 | $1,152.00 |
DisclosureSEC source: 0001393726-20-000114 · wf-form4_158817281758516.xml · nonDerivative · entry 2 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,235 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 27, 2020 Filed Apr 27, 2020 16:19 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
OtherCommon Stock | 56,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000112 · wf-form4_158801875192283.xml · nonDerivative · entry 3 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,322,039 F4 · kind: Corvid Peak Holdings, L.P. ("Corvid Peak") was granted 109,736 RSUs on February 28, 2017 from the Issuer as incentive compensation for the reporting person's services as Executive Chairman of the Issuer. These shares were previously reported as indirectly held by the reporting person. The reporting person received 56,259 shares from Corvid Peak in a pro rata distribution upon vesting in accordance with the reporting person's partnership interests in such entity. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 11:09 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,862 | $5.80 | $16,596.74 |
DisclosureSEC source: 0001393726-20-000116 · wf-form4_158817297211203.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,324,901 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.65 to $5.91, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 11:07 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.49 | $1,098.00 |
DisclosureSEC source: 0001393726-20-000114 · wf-form4_158817281758516.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,435 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 16:16 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.15 | $1,030.00 |
DisclosureSEC source: 0001393726-20-000110 · wf-form4_158801857626843.xml · nonDerivative · entry 2 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,635 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 16:19 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,771 | $5.18 | $14,362.09 |
DisclosureSEC source: 0001393726-20-000112 · wf-form4_158801875192283.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,265,780 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.09 to $5.59, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 16:16 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.09 | $1,018.00 |
DisclosureSEC source: 0001393726-20-000110 · wf-form4_158801857626843.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,835 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 16:19 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,771 | $5.14 | $14,242.94 |
DisclosureSEC source: 0001393726-20-000112 · wf-form4_158801875192283.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,263,009 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.07 to $5.22, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 22, 2020 Filed Apr 23, 2020 09:48 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,771 | $5.25 | $14,547.75 |
DisclosureSEC source: 0001393726-20-000108 · wf-form4_158764966679338.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,260,238 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.17 to $5.31, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 22, 2020 Filed Apr 23, 2020 09:45 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.37 | $1,074.00 |
DisclosureSEC source: 0001393726-20-000106 · wf-form4_158764949819013.xml · nonDerivative · entry 2 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,035 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 09:48 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,771 | $5.04 | $13,954.76 |
DisclosureSEC source: 0001393726-20-000108 · wf-form4_158764966679338.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,257,467 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.00 to $5.10, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 09:45 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.00 | $1,000.00 |
DisclosureSEC source: 0001393726-20-000106 · wf-form4_158764949819013.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,235 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 20, 2020 Filed Apr 21, 2020 10:05 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,771 | $5.26 | $14,564.38 |
DisclosureSEC source: 0001393726-20-000102 · wf-form4_158747792955422.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,254,696 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.17 to $5.35, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 20, 2020 Filed Apr 21, 2020 10:03 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.39 | $1,078.00 |
DisclosureSEC source: 0001393726-20-000100 · wf-form4_158747780524927.xml · nonDerivative · entry 2 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,435 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 17, 2020 Filed Apr 21, 2020 10:05 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,795 | $5.35 | $14,944.87 |
DisclosureSEC source: 0001393726-20-000102 · wf-form4_158747792955422.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,251,925 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.13 to $5.40, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 17, 2020 Filed Apr 21, 2020 10:03 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.08 | $1,016.00 |
DisclosureSEC source: 0001393726-20-000100 · wf-form4_158747780524927.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,635 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 09:31 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,795 | $5.12 | $14,315.99 |
DisclosureSEC source: 0001393726-20-000098 · wf-form4_158713025440697.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,249,130 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.04 to $5.20, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 09:28 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.16 | $1,032.00 |
DisclosureSEC source: 0001393726-20-000096 · wf-form4_158713011559784.xml · nonDerivative · entry 2 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,835 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 09:31 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,795 | $5.17 | $14,438.97 |
DisclosureSEC source: 0001393726-20-000098 · wf-form4_158713025440697.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,246,335 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.05 to $5.20, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 09:28 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.20 | $1,040.00 |
DisclosureSEC source: 0001393726-20-000096 · wf-form4_158713011559784.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,035 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 14, 2020 Filed Apr 15, 2020 09:44 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,795 | $5.41 | $15,120.95 |
DisclosureSEC source: 0001393726-20-000094 · wf-form4_158695824508370.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,243,540 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.34 to $5.48, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 14, 2020 Filed Apr 15, 2020 09:41 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.31 | $1,062.00 |
DisclosureSEC source: 0001393726-20-000092 · wf-form4_158695809822340.xml · nonDerivative · entry 2 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,235 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 09:44 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,795 | $5.30 | $14,821.89 |
DisclosureSEC source: 0001393726-20-000094 · wf-form4_158695824508370.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,240,745 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.11 to $5.48, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 09:41 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.42 | $1,084.00 |
DisclosureSEC source: 0001393726-20-000092 · wf-form4_158695809822340.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,435 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 09, 2020 Filed Apr 10, 2020 11:32 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,477 | $5.66 | $14,012.39 |
DisclosureSEC source: 0001393726-20-000079 · wf-form4_158653271929358.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,237,950 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.52 to $5.81, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 09, 2020 Filed Apr 10, 2020 11:29 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.48 | $1,096.00 |
DisclosureSEC source: 0001393726-20-000077 · wf-form4_158653252240447.xml · nonDerivative · entry 2 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,635 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 08, 2020 Filed Apr 10, 2020 11:32 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,477 | $5.28 | $13,085.99 |
DisclosureSEC source: 0001393726-20-000079 · wf-form4_158653271929358.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,235,473 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.18 to $5.38, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 08, 2020 Filed Apr 10, 2020 15:40 UTC |
Goldwasser LesleyDirector
|
GrantCommon Stock | 5,835 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000088 · wf-form4_158653322789449.xml · nonDerivative · entry 1 Goldwasser Lesley · CIK 0001465575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,416 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| April 08, 2020 Filed Apr 10, 2020 11:29 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.24 | $1,048.00 |
DisclosureSEC source: 0001393726-20-000077 · wf-form4_158653252240447.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,835 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 08, 2020 Filed Apr 10, 2020 11:39 UTC |
Smith Bradley E.Director
|
GrantCommon Stock | 4,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000086 · wf-form4_158653313716137.xml · nonDerivative · entry 1 Smith Bradley E. · CIK 0001579089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,100 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| April 08, 2020 Filed Apr 10, 2020 11:37 UTC |
Mack John EdwardDirector
|
GrantCommon Stock | 4,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000084 · wf-form4_158653300865678.xml · nonDerivative · entry 1 Mack John Edward · CIK 0001381172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,548 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| April 08, 2020 Filed Apr 10, 2020 11:58 UTC |
Friedman Paul MDirector
|
GrantCommon Stock | 4,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000090 · wf-form4_158653429964483.xml · nonDerivative · entry 1 Friedman Paul M · CIK 0001648181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,103 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| April 08, 2020 Filed Apr 10, 2020 11:34 UTC |
Mielle DominiqueDirector
|
GrantCommon Stock | 4,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000081 · wf-form4_158653283509044.xml · nonDerivative · entry 1 Mielle Dominique · CIK 0001759191 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,862 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| April 07, 2020 Filed Apr 8, 2020 10:24 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,477 | $5.09 | $12,605.45 |
DisclosureSEC source: 0001393726-20-000075 · wf-form4_158635587963878.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,232,996 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.05 to $5.13, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 07, 2020 Filed Apr 8, 2020 10:22 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.09 | $1,018.00 |
DisclosureSEC source: 0001393726-20-000073 · wf-form4_158635573542076.xml · nonDerivative · entry 2 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,035 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 10:24 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,477 | $5.15 | $12,766.46 |
DisclosureSEC source: 0001393726-20-000075 · wf-form4_158635587963878.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,230,519 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.08 to $5.25, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 10:22 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $4.99 | $998.00 |
DisclosureSEC source: 0001393726-20-000073 · wf-form4_158635573542076.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,235 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 03, 2020 Filed Apr 6, 2020 09:54 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,028 | $4.96 | $10,048.74 |
DisclosureSEC source: 0001393726-20-000071 · wf-form4_158618123055995.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,228,042 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.88 to $5.01, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 03, 2020 Filed Apr 6, 2020 09:52 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $4.95 | $990.00 |
DisclosureSEC source: 0001393726-20-000069 · wf-form4_158618113241816.xml · nonDerivative · entry 2 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,435 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 02, 2020 Filed Apr 6, 2020 09:54 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,028 | $4.79 | $9,708.04 |
DisclosureSEC source: 0001393726-20-000071 · wf-form4_158618123055995.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,226,014 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.74 to $4.85, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 02, 2020 Filed Apr 6, 2020 09:52 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $4.74 | $948.00 |
DisclosureSEC source: 0001393726-20-000069 · wf-form4_158618113241816.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,635 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 11:34 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,028 | $5.21 | $10,567.91 |
DisclosureSEC source: 0001393726-20-000067 · wf-form4_158584167403299.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,223,986 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.12 to $5.30, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 11:32 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.08 | $1,016.00 |
DisclosureSEC source: 0001393726-20-000065 · wf-form4_158584154538917.xml · nonDerivative · entry 2 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,835 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 11:34 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,028 | $5.43 | $11,014.07 |
DisclosureSEC source: 0001393726-20-000067 · wf-form4_158584167403299.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,221,958 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.38 to $5.47, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 11:32 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.32 | $1,064.00 |
DisclosureSEC source: 0001393726-20-000065 · wf-form4_158584154538917.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,035 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 10:55 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,028 | $5.27 | $10,677.42 |
DisclosureSEC source: 0001393726-20-000063 · wf-form4_158566653554428.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,219,930 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.21 to $5.30, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 10:53 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.25 | $1,050.00 |
DisclosureSEC source: 0001393726-20-000061 · wf-form4_158566638179858.xml · nonDerivative · entry 2 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,235 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 27, 2020 Filed Mar 31, 2020 10:55 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,789 | $5.41 | $9,669.55 |
DisclosureSEC source: 0001393726-20-000063 · wf-form4_158566653554428.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,217,902 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.31 to $5.47, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 27, 2020 Filed Mar 31, 2020 10:53 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.45 | $1,090.00 |
DisclosureSEC source: 0001393726-20-000061 · wf-form4_158566638179858.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,435 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.